Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
Conclusions: These results suggest that EC is a heterogeneous disease that may not conform to traditional, prototypically defined subtypes. The status of ER, PR, and HER2 receptors may have the potential to serve as prognostic indicators for EC, but further analysis is needed to ascertain their prognostic significance.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Caifeng Wang, Davis A. Tran, Melinda Z. Fu, Wei Chen, Sidney W. Fu, Xu Li Tags: Research Paper Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cancer of the Uterus | Cervical Cancer | Endometrial Cancer | HER2 | Hormonal Therapy | Hormones | Radiation Therapy | Statistics | Toxicology